Follow
Modabber F
Modabber F
Senior Advisor DNDi (Retired)
Verified email at dndi.org
Title
Cited by
Cited by
Year
Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial
S Sundar, PK Sinha, M Rai, DK Verma, K Nawin, S Alam, J Chakravarty, ...
The Lancet 377 (9764), 477-486, 2011
3762011
Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan
EAG Khalil, AME Hassan, EE Zijlstra, MM Mukhtar, HW Ghalib, B Musa, ...
The lancet 356 (9241), 1565-1569, 2000
2932000
Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran
I Sharifi, AR FeKri, MR Aflatonian, A Khamesipour, A Nadim, ...
The Lancet 351 (9115), 1540-1543, 1998
2871998
Leishmaniasis vaccine candidates for development: a global overview
A Khamesipour, S Rafati, N Davoudi, F Maboudi, F Modabber
Indian Journal of Medical Research 123 (3), 423, 2006
2682006
Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis
A Khamesipour, Y Dowlati, A Asilian, R Hashemi-Fesharki, A Javadi, ...
Vaccine 23 (28), 3642-3648, 2005
2552005
First generation leishmaniasis vaccines: a review of field efficacy trials
S Noazin, F Modabber, A Khamesipour, PG Smith, LH Moulton, K Nasseri, ...
Vaccine 26 (52), 6759-6767, 2008
2342008
Handbook on isolation, characterization and cryopreservation of Leishmania
DB Evans, D Godfrey, S Lanham, G Lanotte, F Modabber, L Schnur
World Health Organization, 1989
2001989
A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran
AZ Momeni, T Jalayer, M Emamjomeh, A Khamesipour, F Zicker, ...
Vaccine 17 (5), 466-472, 1999
1991999
Vaccines against leishmaniasis
F Modabber
Annals of Tropical Medicine & Parasitology 89 (sup1), 83-88, 1995
1981995
Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation …
RN Coler, YAW Skeiky, K Bernards, K Greeson, D Carter, CD Cornellison, ...
Infection and immunity 70 (8), 4215-4225, 2002
1802002
Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis—A meta-analysis
S Noazin, A Khamesipour, LH Moulton, M Tanner, K Nasseri, F Modabber, ...
Vaccine 27 (35), 4747-4753, 2009
1702009
Failure of a killed Leishmania amazonensis vaccine against American cutaneous leishmaniasis in Colombia
ID Vélez, K Gilchrist, MP Arbelaez, CA Rojas, JA Puerta, CMF Antunes, ...
Transactions of the Royal Society of Tropical Medicine and Hygiene 99 (8 …, 2005
1302005
Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis
P Olliaro, M Vaillant, B Arana, M Grogl, F Modabber, A Magill, O Lapujade, ...
PLoS neglected tropical diseases 7 (3), e2130, 2013
1262013
A review: the current in vivo models for the discovery and utility of new anti-leishmanial drugs targeting cutaneous leishmaniasis
ER Mears, F Modabber, R Don, GE Johnson
PLoS neglected tropical diseases 9 (9), e0003889, 2015
1232015
Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment
AM Musa, EAG Khalil, FAE Mahgoub, SHH Elgawi, F Modabber, ...
Transactions of the Royal Society of Tropical Medicine and Hygiene 102 (1 …, 2008
1192008
Increased myelopoiesis during Leishmania major infection in mice: generation of'safe targets', a possible way to evade the effector immune mechanism.
AM Mirkovich, A Galelli, AC Allison, FZ Modabber
Clinical and experimental immunology 64 (1), 1, 1986
1181986
Experiences with vaccines against cutaneous leishmaniasis: of men and mice
F Modabber
Parasitology 98 (S1), S49-S60, 1989
1161989
Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Institute Pasteur, Paris. 13–15 June, 2006
F Modabber, PA Buffet, E Torreele, G Milon, SL Croft
Kinetoplastid Biology and Disease 6, 1-24, 2007
1092007
Immunochemotherapy for cutaneous leishmaniasis: a controlled trial using killed Leishmania (Leishmania) amazonensis vaccine plus antimonial
J Machado‐Pinto, J Pinto, CA Da Costa, O Genaro, MJ Marques, ...
International journal of dermatology 41 (2), 73-78, 2002
1082002
Vervet Monkeys Vaccinated with Killed Leishmania major Parasites and Interleukin-12 Develop a Type 1 Immune Response but Are Not Protected against …
MM Gicheru, JO Olobo, CO Anjili, AS Orago, F Modabber, P Scott
Infection and immunity 69 (1), 245-251, 2001
1012001
The system can't perform the operation now. Try again later.
Articles 1–20